Benefit-Risk Factors – Different Technological Charasteristics

The FDA Issues Final Guidance – Benefit-Risk Factors to Consider When Determining Substantial Equivalence in Premarket Notifications (510(k)) with Different Technological Characteristics Today, the U.S. Food and Drug Administration (FDA) released the final...

Dr. Jose E. Vidal …You have them all !

Dr. Jose Eduardo Vidal, YOU have them all! It was not destiny that got you a new position. It was your ability to make your own destiny. On behalf of the entire team of Subject Matter Experts from Lean Enterprise Consulting, we wish you the very best on your new...

One Team , One Goal – Your Business Transformation !

  If you’re reading this post, then you’re probably considering utilizing our team expertise at your company. As President and CEO of Lean Enterprise Consulting Inc. (LEC), I’m very pleased to hear that! When you join forces with the great team of...